Treatment
Drug clinical trials
We’re tracking 1,296 recruiting studies that include Drug, each written for real people, not researchers, below.
Recruiting studies
- NCT06406608Recruiting
Personalized drug test for drug-resistant lung cancer
This trial tests a new way to choose your next treatment by growing a mini version of your tumor (an organoid) in a lab and seeing which drugs kill it best. It is for people with drug-resistant non-small cell lung cancer who have already tried at least two standard treatments.
Zhengzhou, HenanAges 18–75 - NCT06457776Recruiting
Jaw bone health in people taking bone-strengthening drugs
This study looks at how a specific jaw problem (osteonecrosis) may happen in people taking bone-strengthening medications. It aims to better understand and manage this side effect.
RomaAges 18 years+ - NCT06551662Recruiting
Balloon vs. stent for split artery blockages
This trial compares two ways to open a blocked artery that splits into two branches (a bifurcation): using a balloon coated with medicine (drug-coated balloon, or DCB) versus a drug-eluting stent (DES). The goal is to see which approach works better for patients with this type of blockage.
MilanAges 18 years+ - NCT06566560Recruiting
Using unused cancer pills safely
This trial tests if unused oral cancer pills that were stored at room temperature can be safely given to other patients. If you take a room-temperature oral cancer pill, you may be able to help reduce medication waste.
Nijmegen, GelderlandAges Any age - NCT06590428Recruiting
Tracking linezolid levels for rifampin-resistant TB treatment
This study checks if measuring the amount of linezolid medicine in your blood helps treat rifampin-resistant tuberculosis more safely and effectively. It is for people who have already started a treatment plan that includes linezolid.
East London, Eastern CapeAges 18 years+ - NCT06658080Recruiting
Testing drugs on fluid from breast cancer
This trial uses fluid from the chest or belly of breast cancer patients to grow tiny tumor models in the lab. These models help doctors find which drugs might work best for each patient.
Hangzhou, ZhejiangAges 18–70 - NCT06677970RecruitingPhase 3
Blood Pressure Control After Stroke Thrombectomy
This trial tests whether carefully lowering blood pressure after a mechanical clot removal procedure for stroke can improve outcomes. If you've had a large vessel stroke that was successfully treated with thrombectomy, this study will help guide blood pressure management in the recovery period.
Seoul, SeoulAges 20 years+ - NCT06693960RecruitingEarly Phase 1
Oregano and drug interaction study
This study looks at how oregano affects the way your body processes certain medications. It might help patients understand if oregano can change how drugs work.
Spokane, WashingtonAges 18–64 - NCT06716203RecruitingPhase 3
Study of BGM0504 for type 2 diabetes not well controlled by diet and exercise
This trial tests a new medication called BGM0504 for people with type 2 diabetes that is not well managed with diet and exercise alone. It aims to see if the drug can help lower blood sugar levels.
Beijing, Beijing MunicipalityAges 18–75 - NCT06716216RecruitingPhase 3
Study of BGM0504 for people with type 2 diabetes
This trial tests an investigational drug called BGM0504 in people with type 2 diabetes who are already taking metformin or metformin plus another diabetes medicine. It aims to see if the drug can help lower blood sugar levels.
Beijing, Beijing MunicipalityAges 18–75 - NCT06757140RecruitingPhase 1/Phase 2
Opioid and sedative-like drug interaction study
This study explores how opioids and sedative-like drugs interact in the body. It aims to understand their combined effects, which could help improve safety for people who use these drugs.
Lexington, KentuckyAges 18–55 - NCT06800612Recruiting
Cancer drug therapy study for gynecologic or breast cancers
This study looks at how well different cancer drugs work for women with breast or gynecologic cancers. Researchers will review medical records to see how patients responded to treatment over time. If you have been treated for breast or gynecologic cancer since 2010, you may be eligible.
BolognaAges 18 years+ - NCT07680842Recruiting
Non-invasive ultrasound for drug-resistant epilepsy
This study tests a non-invasive focused ultrasound treatment for people with epilepsy that doesn't respond to medications. The goal is to see if this gentle ultrasound can reduce seizures without surgery.
San Francisco, CaliforniaAges 21–65 - NCT07397845Recruiting
Stents vs drug-coated balloons for small or complex heart vessels
This trial compares two treatments—stents and paclitaxel-coated balloons—for people with narrowed heart arteries that are small, long, or complex. It aims to find which option works better to restore blood flow.
Lucerne, Canton of LucerneAges 18 years+ - NCT02299921Recruiting
Alcohol and drug effects on immunity in ICU breathing patients
This study looks at how alcohol and other drugs can affect the body’s immune system in people who are very sick in the ICU due to breathing problems. It may help doctors better understand immune changes during critical illness and respiratory failure.
Aurora, ColoradoAges 18–90 - NCT02961413Recruiting
Study of drug-related liver injury in China
This study follows people who developed liver injury from a medicine (not from other causes). It aims to better describe different types and severities of drug-related liver injury and may help improve how clinicians recognize and manage it.
ShanghaiAges Any age - NCT07477119RecruitingPhase 4
Personalized linezolid dosing for drug-resistant TB treatment
This trial tests whether adjusting the dose of linezolid based on regular blood tests can help people with multidrug-resistant tuberculosis (MDR-TB) tolerate the medication better while on the BPaL or BPaL-M regimen. It aims to reduce side effects and improve treatment success.
ConakryAges 15 years+ - NCT07100054Enrolling by invitation
Genetic markers for CDK4/6 inhibitor therapy in breast cancer
This trial looks at how genetic markers and other substances in your blood might help personalize treatment with CDK4/6 inhibitors, a targeted therapy for breast cancer. It aims to find better ways to predict which patients will benefit most.
London, OntarioAges 18 years+ - NCT07764094Recruiting
Balloon treatment for blocked heart arteries
This trial tests how the way a drug-coated balloon is used during a heart procedure affects outcomes for people with stable heart disease or unstable angina. It may help doctors find the best technique to keep arteries open.
Nanjing, JiangsuAges 18–80 - NCT07672405RecruitingPhase 2
Sorfequiline-based treatment for new drug-sensitive TB
This study tests a new medicine called sorfequiline, given in a combination regimen, to treat adults with drug-sensitive TB. It aims to see if sorfequiline can work as well as or better than standard treatment and shorten the time to cure.
Port Elizabeth, BethelsdorpAges 18–65 - NCT07147231RecruitingPhase 1/Phase 2
Pidnarulex plus cemiplimab for MSS colorectal cancer
This trial tests two drugs together: pidnarulex (a targeted therapy) and cemiplimab (an immunotherapy that helps your immune system fight cancer). It is for people with advanced colorectal cancer that is microsatellite stable (MSS) and has not responded to current treatments, especially if their tumor has a MYC or FBXW7 change.
Washington D.C., District of ColumbiaAges 18 years+ - NCT07758907Enrolling by invitation
Testing a device that reads fingerprints for drug screening
This trial tests a new drug screening system that reads fingerprints to detect drugs in the body. It will check if certain medications interfere with the device's accuracy, which may lead to faster and easier drug testing in the future.
Marlton, New JerseyAges 18–55 - NCT07755397RecruitingPhase 1
Study of JBI-778 for lung, brain, and salivary gland tumors
This trial tests a new oral medication, JBI-778, in patients with certain types of lung cancer, brain tumors, or salivary gland cancer. The drug is designed to target specific genetic changes in these tumors, and the study aims to assess its safety and effectiveness.
Surat, GujaratAges 18 years+ - NCT05789173RecruitingEarly Phase 1
Testing how genetics affect drug levels with methadone
This early study tests how a person’s genetic makeup may change how fast certain medicines move through the body. It compares drug levels when combined with methadone and tizanidine, aiming to understand safer dosing and effects.
Indianapolis, IndianaAges 18–65
Common questions
- Are there clinical trials studying Drug?
- Yes. Clin2 currently lists 1,296 recruiting studies that include Drug, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Drug trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Drug an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Drug or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.